Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.3798
+0.0228 (6.39%)
At close: Apr 24, 2026, 4:00 PM EDT
0.3600
-0.0198 (-5.21%)
After-hours: Apr 24, 2026, 7:12 PM EDT
Cosmos Health Employees
Cosmos Health had 149 employees as of December 31, 2024. The number of employees increased by 26 or 21.14% compared to the previous year.
Employees
149
Change (1Y)
26
Growth (1Y)
21.14%
Revenue / Employee
$438,066
Profits / Employee
-$128,490
Market Cap
19.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 149 | 26 | 21.14% |
| Dec 31, 2023 | 123 | 21 | 20.59% |
| Dec 31, 2022 | 102 | 7 | 7.37% |
| Dec 31, 2021 | 95 | 6 | 6.74% |
| Dec 31, 2020 | 89 | 18 | 25.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cardinal Health | 57,700 |
| Cencora | 51,000 |
| McKesson | 51,000 |
| Henry Schein | 25,000 |
| Accendra Health | 6,500 |
| 111, Inc. | 1,238 |
| EDAP TMS | 310 |
| Synergy CHC | 28 |
COSM News
- 4 days ago - Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products - Accesswire
- 5 days ago - Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio - Accesswire
- 8 days ago - Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health - Accesswire
- 9 days ago - Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30% - Accesswire
- 10 days ago - Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments - Accesswire
- 12 days ago - Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units - Accesswire
- 15 days ago - Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months - Accesswire
- 17 days ago - Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction - Accesswire